Topoisomerase IIα gene amplification in gastric carcinomas: correlation with the HER2 gene. An immunohistochemical, immunoblotting, and multicolor fluorescence in situ hybridization study

Assessment of Methods for Tissue-Based Detection of the HER-2/neu Alteration in Human Breast Cancer: A Direct Comparison of Fluorescence In Situ Hybridization and Immunohistochemistry

Giovanni M. Pauletti, Suganda Dandekar, Hong-Mei Rong et al. · Journal of Clinical Oncology · 2000 · 685 citations

Medicine, Cancer Biology, Oncology +17

Amplification of HER-2 in gastric carcinoma: association with Topoisomerase IIα gene amplification, intestinal type, poor prognosis and sensitivity to trastuzumab

Minna Tanner, Maija Hollmén, Teemu T. Junttila et al. · Annals of Oncology · 2005 · 664 citations

Medicine, Cancer Biology, Oncology +15

erbB-2 and Response to Doxorubicin in Patients With Axillary Lymph Node-Positive, Hormone Receptor- Negative Breast Cancer

Soonmyung Paik, John Bryant, Chanheun Park et al. · JNCI Journal of the National Cancer Institute · 1998 · 656 citations

Medicine, Pharmacology, Breast Oncology +12

erbB-2, p53, and Efficacy of Adjuvant Therapy in Lymph Node-Positive Breast Cancer

Ann D. Thor, Donald A. Berry, Daniel R. Budman et al. · JNCI Journal of the National Cancer Institute · 1998 · 618 citations · Full text

Medicine, Oncology, Pharmacology +16

Amplification and Deletion of Topoisomerase IIα Associate with ErbB-2 Amplification and Affect Sensitivity to Topoisomerase II Inhibitor Doxorubicin in Breast Cancer

Tero A.H. Järvinen, Minna Tanner, Virpi Rantanen et al. · American Journal Of Pathology · 2000 · 385 citations · Full text

Medicine, Cancer Biology, Oncology +14